Smoking weed produces a cluster of visible eye changes that most people can spot across a room: bloodshot redness, a glassy or watery sheen, noticeably droopy lids, and sometimes a slightly glazed or unfocused look. The most universal of these is the red eye, which happens not because smoke irritates the surface (though it can) but because THC lowers blood pressure and dilates blood vessels throughout the body, including the tiny ones covering the whites of your eyes. That vascular shift is the same reason cannabis has been studied for glaucoma, and it kicks in whether you smoke, vape, or eat an edible.
Why Your Eyes Turn Red
Red eyes after cannabis are driven by vasodilation, the widening of blood vessels. When THC enters your bloodstream, it activates cannabinoid receptors that relax smooth muscle in blood-vessel walls, including the fine capillaries running across the conjunctiva, the clear membrane over the white of your eye. As those vessels expand, they carry more blood, and because the conjunctiva is nearly transparent, the redness becomes visible almost immediately.
Research on THC’s ocular toxicity profile has confirmed that delta-9-THC specifically causes conjunctival erythema (the clinical term for red eyes) along with chemosis, a swelling of the conjunctival tissue. In one animal study, these changes were described as “quite severe” with pure THC, somewhat milder with whole marijuana extract, and absent with CBD alone.1PubMed. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol That finding matters for practical purposes: if you use a CBD-only product, the classic red-eye look is far less likely. It is the THC that drives the bulk of the visible redness.
The redness is also dose-dependent. A small hit may produce only a faint pinkish tinge, while heavier consumption tends to turn the whites of the eyes bright red. Individual variation matters too. People whose blood pressure runs on the lower side to begin with sometimes get dramatically red eyes from modest doses, while others who use cannabis regularly may notice their eyes redden less over time as a partial tolerance develops to the cardiovascular effects.
Droopy, Heavy-Lidded Eyes
After redness, the second most recognizable sign is the “stoned squint,” a visible drooping of the upper eyelids that makes the eyes look half-closed. Clinically this is called ptosis, and cannabis-associated ptosis has been documented across multiple species in research settings. Animal studies using rats, mice, and primates have consistently found that both THC and the body’s own endocannabinoid, anandamide, produce measurable eyelid drooping. The effect appears to be myogenic, meaning it comes from reduced function of the levator muscle that holds the upper lid open, rather than from nerve damage.2PubMed Central. Association Between Cannabis and the Eyelids
In humans, the droopy-lid look is extremely common among people who test positive for THC. A study of impaired drivers found that roughly 86% of those with THC-positive blood samples showed ptosis during standardized field sobriety testing.3Clinical Ophthalmology. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review That is a strikingly high proportion and suggests droopy eyelids are nearly as reliable a sign of recent cannabis use as redness.
Whether the ptosis is purely temporary or can become longer-lasting with chronic heavy use is not fully settled. The animal literature shows the effect is dose-dependent: in mice, a higher THC dose produced more eyelid closure than a lower one, and increasing doses of CBD also correlated with greater drooping.2PubMed Central. Association Between Cannabis and the Eyelids For most recreational users, the heavy-lidded look resolves as the high wears off, but researchers have flagged this as a gap in the evidence that needs more human data.
What Happens to Your Pupils
Pupil changes after cannabis are real but surprisingly inconsistent across studies, which is part of why the “stoner pupil” is harder to characterize than the “stoner red eye.” In a controlled trial giving intravenous THC to healthy volunteers who did not regularly use cannabis, researchers found that the pupil’s ability to react to light was significantly blunted. The relative amplitude of the pupillary light reflex dropped from about 23.5% to 15% within 20 minutes of THC administration, meaning the pupil constricted less in response to a flash of light. Overall pupil size actually decreased slightly.4PubMed Central. Effects of intravenous d9-THC on pupillary reaction and pupil size: a prospective, placebo-controlled trial in healthy volunteers not regularly consuming cannabis
That seems straightforward enough, except other research has found the opposite. A study using a pupillometer on cannabis users reported an increase in pupil size after use, and the authors themselves noted their findings “appear contradictory to previous research literature.”5Journal of Clinical Forensic Medicine. Use of a pupillometer to assess change in pupillary size post-cannabis Meanwhile, data from Drug Recognition Expert examinations of suspected cannabis-impaired drivers found that dilated pupils were a significant indicator, along with a phenomenon called “rebound dilation,” where the pupil briefly constricts in response to light but then widens again instead of staying small.6PubMed. Drug Recognition Expert (DRE) examination characteristics of cannabis impairment
Why the contradiction? Several factors probably play a role. THC affects both the sympathetic and parasympathetic nervous systems, which push pupil size in opposite directions. The net result at any given moment may depend on the dose, the route of administration, the user’s tolerance, ambient lighting, and how much time has passed since consumption. The most consistent finding across studies is not a specific direction of change but rather a sluggish pupillary light reflex: the pupil reacts to light more slowly and less completely. That sluggishness, combined with rebound dilation, is actually what trained observers like drug recognition experts look for, rather than simple dilation or constriction.
The Glassy, Dry-Eye Effect
Part of the “glazed” look that marks cannabis-affected eyes comes from changes in tear production. THC interacts with CB1 cannabinoid receptors in the lacrimal gland, the small gland above each eye that produces the watery layer of your tear film. In male mice, THC cut tear volume by more than half, from about 5.0 mm on a standardized test thread down to 2.0 mm. When the same experiment was run on mice that lacked CB1 receptors entirely, the tear-reducing effect disappeared, confirming the receptor’s role.7PubMed Central. THC Regulates Tearing via Cannabinoid CB1 Receptors
An unexpected wrinkle in this research is a strong sex difference. Female mice given the same THC dose did not show reduced tearing at all. In fact, activating their CB1 receptors with a potent synthetic agonist roughly tripled tear production rather than cutting it.7PubMed Central. THC Regulates Tearing via Cannabinoid CB1 Receptors Whether this sex difference translates cleanly to humans is not yet certain, but it could help explain why some people report bone-dry eyes after smoking while others barely notice a change. Hormonal differences in how the endocannabinoid system functions in the lacrimal gland may matter more than people realize.
In practical terms, the dry-eye effect is why many cannabis users reach for eye drops. Artificial tears can rehydrate the eye surface and, because many over-the-counter drops also contain a mild vasoconstrictor, they can reduce redness at the same time. The dryness typically resolves as THC clears the system, but chronic heavy users who already have borderline dry-eye conditions may find cannabis aggravates their symptoms more persistently.
Intraocular Pressure and the Glaucoma Connection
Cannabis lowers the pressure inside the eye. This has been known since the 1970s and is the basis of the long-running conversation about marijuana and glaucoma treatment. The pressure drop appears to work primarily by increasing the outflow of aqueous humor, the fluid that fills the front chamber of the eye, rather than by reducing its production. The response is rapid, consistent with a vascular mechanism that adjusts quickly rather than a slow structural change in the eye’s drainage tissue.8Archives of Ophthalmology. Marijuana Smoking vs Cannabinoids for Glaucoma Therapy
The drop in intraocular pressure is real but comes with a catch that has kept cannabis from becoming a standard glaucoma treatment: the effect only lasts a few hours per dose. Managing glaucoma requires sustained, round-the-clock pressure control, and the systemic side effects of staying perpetually high make this impractical for most patients. The American Academy of Ophthalmology and similar professional bodies have generally concluded that while the pressure-lowering effect is genuine, conventional glaucoma medications are more effective and more practical.
For the average person smoking recreationally, the temporary pressure drop is harmless. You will not feel it happening, and it does not contribute to the visible appearance of your eyes in any way a friend would notice. The redness, droopy lids, and glassy look are all separate effects from the pressure change.
Subtle Vision Changes You Might Not Attribute to Weed
Beyond the cosmetic changes visible to others, cannabis also affects how well you see, particularly in low-light conditions. Research comparing regular cannabis users to non-users found that users had measurably poorer contrast sensitivity under dim lighting, meaning they were worse at distinguishing objects from their backgrounds when the lights were low. They also needed more visual information to correctly perceive motion at all light levels tested.9PubMed. Contrast sensitivity and motion discrimination in cannabis users
The frequency of cannabis use correlated with the degree of impairment: people who used cannabis more often had worse contrast sensitivity and needed even higher motion coherence thresholds to detect movement.9PubMed. Contrast sensitivity and motion discrimination in cannabis users This has obvious implications for driving at night or navigating poorly lit environments. The person in the car next to you at dusk who smoked an hour ago does not just have slow reaction times; they are literally seeing the road with less clarity and detecting moving objects less efficiently.
These effects on visual processing are thought to involve cannabinoid receptors in the retina and visual cortex rather than just changes to the eye’s surface or pupil. In other words, it is not that light is entering the eye differently; it is that the brain is processing the visual signal less sharply. Most users are unaware of these changes while high because the subjective experience does not feel like “bad vision” in the way that needing glasses does. It feels more like a subtle general softening that blends into the overall altered state.
How Law Enforcement Reads Your Eyes
If you have ever wondered what a police officer is looking for during a roadside encounter, the eyes are a major focus. Drug Recognition Expert protocols include systematic examination of pupil size under different lighting conditions, pupillary reaction speed, convergence (the ability to track an object moving toward the nose), and eyelid position. In a study comparing DRE examination results for THC-positive drivers against controls, the cannabis group showed significantly dilated pupils, elevated pulse, and higher systolic blood pressure compared to unimpaired subjects.6PubMed. Drug Recognition Expert (DRE) examination characteristics of cannabis impairment
Rebound dilation was another strong indicator. In this test, the officer shines a light into the eye and watches the pupil constrict, then observes whether it bounces back to a larger size rather than holding steady. That rebound pattern is considered characteristic of cannabis and a handful of other drug categories. Combined with the near-universal ptosis mentioned earlier, officers trained in DRE protocols can assemble a fairly specific picture from eye signs alone, though the system is designed to use multiple body-system observations together rather than relying on any single indicator.
It is worth noting that none of these eye signs constitute proof of impairment in the way a blood alcohol level does. DRE evaluations are opinion-based assessments, and their accuracy has been debated in court. Eye signs can overlap between drug categories, and individual baseline variation means some perfectly sober people have sluggish pupils or naturally droopy lids. Still, the combination of red, glassy eyes with impaired pupillary response and visible ptosis is enough to trigger further investigation in most jurisdictions.
Synthetic Cannabinoids Hit the Eyes Differently
Products sold as “Spice,” “K2,” or “Bonzai” contain synthetic cannabinoids that bind to the same receptors as THC but often with much greater potency and less predictable effects. A case-control study comparing the eyes of synthetic cannabinoid users to non-users found significantly lower intraocular pressure in active users, similar to the effect of natural THC. But the study also detected structural changes deeper in the eye: the choroid, the vascular layer behind the retina, was thinner in synthetic cannabinoid users, and a measure of the choroid’s vascular proportion was altered in both current and past users compared to controls.10PubMed Central. Ocular effects of synthetic cannabinoids: a case-control study
These choroidal changes are not something you would see in the mirror, but they suggest that synthetic cannabinoids may affect the eye’s blood supply in ways that plant-derived cannabis does not, or at least not to the same degree. The clinical significance of thinner choroids in young, otherwise healthy people is not fully understood, but the choroid is responsible for nourishing the outer retina, and long-term thinning could theoretically affect retinal health. This is an area where the synthetics appear to carry risks beyond what you would expect from regular marijuana.
Edibles, Secondhand Smoke, and Other Routes
A common misconception is that red eyes from cannabis are caused by the smoke itself irritating the eye’s surface. Smoke does irritate eyes, as anyone who has sat too close to a campfire knows. In a controlled secondhand-exposure experiment, non-smokers in a sealed, unventilated room with cannabis smokers reported mild eye irritation, particularly those who removed protective goggles during the session.11PubMed Central. Non-Smoker Exposure to Secondhand Cannabis Smoke II: Effect of Room Ventilation on the Physiological, Subjective, and Behavioral/Cognitive Effects But surface irritation from smoke is different from the vasodilation-driven redness caused by THC in the bloodstream.
The proof is simple: edibles cause red eyes too. When you eat a cannabis product, no smoke touches your eyes at all, yet the redness, droopy lids, and dryness show up just the same once the THC is absorbed and reaches systemic circulation. Vaping typically produces less surface irritation than combustion, but the THC-driven eye effects are identical. This is why eye drops help whether you smoked, vaped, or ate a brownie. The cosmetic changes are coming from the inside out.
Secondhand cannabis smoke exposure in well-ventilated spaces appears to produce little beyond mild surface irritation, and even in the extreme unventilated condition studied, the eye complaints were described as mild. Passive exposure is unlikely to produce the classic red, droopy, glassy appearance unless the ventilation is essentially nonexistent and the smoke concentration is high.
When Children Are Exposed
With cannabis legalization expanding and edible products increasingly common in households, accidental ingestion by young children has become a genuine pediatric concern. The eye signs in children are not identical to what you see in adults. Rather than just red, half-closed eyes, children who accidentally consume cannabis edibles commonly present with pronounced drowsiness and somnolence, and in severe cases can develop respiratory depression and seizures.12PubMed Central. Accidental cannabis ingestion in young children A toddler with unexplained extreme sleepiness, poorly reactive pupils, and droopy eyelids in a household where cannabis products are present should raise immediate concern.
The reason children are more vulnerable is partly body weight and partly immature metabolic pathways. A dose that produces a pleasant buzz in a 170-pound adult can overwhelm a 30-pound child. The eye-related symptoms in pediatric cases tend to be part of a broader clinical picture including nausea, vomiting, and altered consciousness, rather than the isolated cosmetic changes adults experience. If you keep cannabis products at home, treating them with the same locked-storage approach used for medications and cleaning products can prevent these exposures.
How Long the Eye Effects Last and Whether You Can Hide Them
For most people, the visible eye changes from cannabis follow a predictable timeline. Redness typically begins within minutes of inhalation (or 30 to 90 minutes after eating an edible) and peaks around the same time the subjective high does. With smoking or vaping, the red eye usually starts fading after two to three hours. With edibles, it can persist for four to six hours or longer because THC is released more gradually from the digestive system.
Vasoconstricting eye drops (the kind marketed for “getting the red out”) are the most popular countermeasure and genuinely work for the redness. They shrink the dilated blood vessels on the eye’s surface within a few minutes. They do nothing for droopy lids, sluggish pupils, or the glassy quality that comes from altered tear production. Sunglasses obviously mask everything but are less practical indoors. Staying well-hydrated and using artificial tears can help with the dryness component.
Tolerance plays a meaningful role. People who use cannabis daily often report that their eyes barely redden anymore, while the same strain and dose in an occasional user produces vivid redness. This tracks with what we know about cannabinoid receptor downregulation with chronic exposure. The receptors that mediate vasodilation become less responsive over time, blunting the effect. The same tolerance pattern seems to apply to ptosis and tear changes, though the evidence for those is less detailed in humans.
One variable that surprises people is that different strains or products can produce different degrees of eye redness, and it is not always predictable from THC content alone. Terpenes, minor cannabinoids, and individual metabolic differences all play a role. Some users find that particular products consistently give them worse red eye than others at comparable THC levels, suggesting there are additional pharmacological actors beyond THC itself that influence ocular blood flow.